Determining the incidence of rare diseases
Extremely rare diseases are increasingly recognized due to wide-spread, inexpensive genomic sequencing. Understanding the incidence of rare disease is important for appreciating its health impact and allocating recourses for research. However, estimating incidence of rare disease is challenging because the individual contributory alleles are, themselves, extremely rare. We propose a new method to determine incidence of rare, severe, recessive disease in non-consanguineous populations that use known allele frequencies, estimate the combined allele frequency of observed alleles and estimate the number of causative alleles that are thus far unobserved in a disease cohort. Experiments on simulated and real data show that this approach is a feasible method to estimate the incidence of rare disease in European populations but due to several limitations in our ability to assess the full spectrum of pathogenic mutations serves as a useful tool to provide a lower threshold on disease incidence.
KeywordsRare disease Genetics Incidence Simulation
The author would like to thank Drs. Mario Cleves, Charlotte Hobbs, Michelle Clark, Svasti Haricharan, David Dimmock and Sara Raskin for commenting on the manuscript. They would also like to thank the TESS foundation, A 501(c)(3) nonprofit corporation, (https://tessresearch.org/) for providing cohort data. This work was funded in part by gifts from the Liguori Family, John Motter and Effie Simanikas, Ernest and Evelyn Rady, and Rady Children’s Hospital San Diego.
Compliance with ethical standards
Conflict of interest
MNB is a member of the TESS scientific advisory board.
- Rode J (2005) Rare diseases: understanding this public health priority. EURORDIS, Paris, France. https://www.eurordis.org/IMG/pdf/princeps_document-EN.pdf
- Updated Study Analyzes Use and Cost of Orphan Drugs (2018) In: NORD Natl Organ Rare Disord. https://rarediseases.org/updated-study-analyzes-use-and-cost-of-orphan-drugs/. Accessed 19 Nov 2019